OT: Hey cj, I looked at their February Investors presentation and it looks like an interesting company. However, Phase II results are not in yet and I would not invest until Phase II is positive and they raise more cash for a Phase III as they will need to dilute sometime mid to late next year to raise more cash based on their burn rate.
Its worth paying a little more with a successful Phase II study and financing shored up to a potential marketing of the drug. Right now I am in PATH and they are running out of cash with an approved product trying to partner for almost 7 months now! There is always the potential of a buyout for BIOD prior to Phase III study or even after a phase III study but to me the risk versus reward doesn't justify buying it now with out any other catalyst that I could see other than Phase II data and if not good stock takes a bath so thats my 2 cents at least.
WMGIZ volume is picking up as we get close to the 6 month mark August 5th I believe since FDA sent out and BMTI/Wright sent back responses. I cannot believe it has taken over a year since the second submission and 2 years if one includes first FDA NDA!